It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
The escalating prevalence of insulin resistance (IR) and type 2 diabetes mellitus (T2D) underscores the urgent need for improved early detection techniques and effective treatment strategies. In this context, our study presents a proteomic analysis of post-exercise skeletal muscle biopsies from individuals across a spectrum of glucose metabolism states: normal, prediabetes, and T2D. This enabled the identification of significant protein relationships indicative of each specific glycemic condition. Our investigation primarily leveraged the machine learning approach, employing the white-box algorithm relative evolutionary hierarchical analysis (REHA), to explore the impact of regulated, mixed mode exercise on skeletal muscle proteome in subjects with diverse glycemic status. This method aimed to advance the diagnosis of IR and T2D and elucidate the molecular pathways involved in its development and the response to exercise. Additionally, we used proteomics-specific statistical analysis to provide a comparative perspective, highlighting the nuanced differences identified by REHA. Validation of the REHA model with a comparable external dataset further demonstrated its efficacy in distinguishing between diverse proteomic profiles. Key metrics such as accuracy and the area under the ROC curve confirmed REHA’s capability to uncover novel molecular pathways and significant protein interactions, offering fresh insights into the effects of exercise on IR and T2D pathophysiology of skeletal muscle. The visualizations not only underscored significant proteins and their interactions but also showcased decision trees that effectively differentiate between various glycemic states, thereby enhancing our understanding of the biomolecular landscape of T2D.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Medical University of Bialystok, Clinical Research Centre, Białystok, Poland (GRID:grid.48324.39) (ISNI:0000000122482838); Medical University of Bialystok, Department of Medical Biology, Białystok, Poland (GRID:grid.48324.39) (ISNI:0000 0001 2248 2838)
2 Bialystok University of Technology, Faculty of Computer Science, Białystok, Poland (GRID:grid.446127.2) (ISNI:0000 0000 9787 2307)
3 Medical University of Bialystok, Clinical Research Centre, Białystok, Poland (GRID:grid.48324.39) (ISNI:0000000122482838); Medical University of Bialystok, Department of Endocrinology, Diabetology and Internal Medicine, Białystok, Poland (GRID:grid.48324.39) (ISNI:0000 0001 2248 2838); Broad Institute of Harvard and MIT, Programs in Metabolism and Medical and Population Genetics, Cambridge, USA (GRID:grid.66859.34) (ISNI:0000 0004 0546 1623)
4 Medical University of Bialystok, Department of Medical Biology, Białystok, Poland (GRID:grid.48324.39) (ISNI:0000 0001 2248 2838)
5 Medical University of Bialystok, Clinical Research Centre, Białystok, Poland (GRID:grid.48324.39) (ISNI:0000000122482838); Medical University of Bialystok, Department of Endocrinology, Diabetology and Internal Medicine, Białystok, Poland (GRID:grid.48324.39) (ISNI:0000 0001 2248 2838)